Psoriasis and tuberculosis (TB) are 2 conditions with high prevalence in the general population, often present simultaneously in the same patient. The crucial cytokine involved in the pathogenesis of psoriasis, tumor necrosis factor alpha (TNF-alpha), also is important in defending against mycobacteria. Therefore, it is important to screen patients for a latent TB infection (LTBI) while they are undergoing treatment with TNF-alpha antagonists. We present a case of a patient with psoriasis and LTBI who underwent treatment with etanercept.
Severe psoriasis with positive TB-gold test in treatment with Etanercept: case report / Potenza, Concetta; Bernardini, Nicoletta; Nicolucci, Francesca; Tolino, Ersilia; Skroza, Nevena. - In: CUTIS. - ISSN 0011-4162. - 90:3(2012), pp. 120-122.
Severe psoriasis with positive TB-gold test in treatment with Etanercept: case report
POTENZA, Concetta;BERNARDINI, NICOLETTA;NICOLUCCI, FRANCESCA;TOLINO, ERSILIA;SKROZA, Nevena
2012
Abstract
Psoriasis and tuberculosis (TB) are 2 conditions with high prevalence in the general population, often present simultaneously in the same patient. The crucial cytokine involved in the pathogenesis of psoriasis, tumor necrosis factor alpha (TNF-alpha), also is important in defending against mycobacteria. Therefore, it is important to screen patients for a latent TB infection (LTBI) while they are undergoing treatment with TNF-alpha antagonists. We present a case of a patient with psoriasis and LTBI who underwent treatment with etanercept.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
